78,327 Shares in Agilent Technologies, Inc. $A Bought by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC purchased a new stake in Agilent Technologies, Inc. (NYSE:A) during the 1st quarter, HoldingsChannel reports. The firm purchased 78,327 shares of the medical research company’s stock, valued at approximately $9,041,000.

Other hedge funds have also added to or reduced their stakes in the company. Fiduciary Trust Co boosted its stake in shares of Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after purchasing an additional 77 shares in the last quarter. Freestone Capital Holdings LLC raised its stake in Agilent Technologies by 2.0% in the fourth quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock worth $574,000 after buying an additional 84 shares in the last quarter. Plan A Wealth LLC raised its stake in Agilent Technologies by 3.2% in the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock worth $403,000 after buying an additional 92 shares in the last quarter. IHT Wealth Management LLC lifted its holdings in Agilent Technologies by 4.9% in the fourth quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock worth $278,000 after buying an additional 96 shares during the period. Finally, PFG Investments LLC lifted its holdings in Agilent Technologies by 3.8% in the first quarter. PFG Investments LLC now owns 2,837 shares of the medical research company’s stock worth $323,000 after buying an additional 104 shares during the period. 87.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on A shares. Royal Bank Of Canada assumed coverage on Agilent Technologies in a report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price on the stock. Barclays raised their target price on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. HSBC dropped their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Bank of America raised Agilent Technologies from a “neutral” rating to a “buy” rating and reduced their price target for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Finally, Sanford C. Bernstein began coverage on Agilent Technologies in a report on Friday, June 26th. They issued an “outperform” rating and a $155.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $159.35.

Agilent Technologies Price Performance

Shares of A opened at $138.32 on Monday. The stock has a market cap of $39.06 billion, a PE ratio of 27.77, a price-to-earnings-growth ratio of 2.46 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The firm’s 50-day simple moving average is $132.35 and its two-hundred day simple moving average is $125.14.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same period last year, the business earned $1.31 earnings per share. The business’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts anticipate that Agilent Technologies, Inc. will post 6.01 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a dividend of $0.255 per share. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s payout ratio is presently 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.